Activation of spinal histamine H3 receptors inhibits mechanical nociception

European Journal of Pharmacology

Volumn 470, Issue 3, 2003, Pages 139-147

  Cannon, Keri E ^a   Nalwalk, Julia W ^a   Stadel, Rebecca ^a   Ge, P ^b   Lawson, D ^b   Silos Santiago, I ^b   Hough, Lindsay B ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

Antinociception; H3 receptor; Immepip

Indexed keywords

ALPHA METHYLHISTAMINE; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; IMMEPIP; THIOPERAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; DOSE TIME EFFECT RELATION; DRUG EFFECT; FEMALE; KNOCKOUT MOUSE; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; TAIL FLICK TEST; WILD TYPE;

EID: 0037531236     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01737-0     Document Type: Article

References (61)

1. Abram S.E. Spinally delivered analgesic drugs. Yaksh T. Spinal Drug Delivery. 1999;457-476 Elsevier, Amsterdam.
2. 3) of histamine receptors. Nature. 302:1983;832-837.
3. 3-receptors. Nature. 327:1987;117-123.
4. Beck P.W., Handwerker H.O., Zimmermann M. Nervous outflow from the cat's foot during noxious radiant heat stimulation. Brain Res. 67:1974;373-386.
5. Bianchi C., Franceschini J. Experimental observations on Haffner's method for testing analgesic drugs. Br. J. Pharmacol. 9:1954;280-284.
6. 3 receptor activation in rats. Br. J. Pharmacol. 119:1996;1656-1664.
7. 3 receptors in the modulation of noradrenaline release from rat spinal cord slices. Eur. J. Pharmacol. 287:1995;127-133.
8. 3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin. Eur. J. Pharmacol. 296:1996;223-225.
9. 3 receptor. Biochem. J. 355:2001;279-288.
10. Craig A.D., Andrew D. Responses of spinothalamic lamina I neurons to repeated brief contact heat stimulation in the cat. J. Neurophysiol. 87:2002;1902-1914.
11. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
12. 3 receptors in isolated perfused rabbit lungs. Eur. J. Pharmacol. 277:1995;243-250.
13. 3 receptor isoforms with different brain expression and signaling properties. Mol. Pharmacol. 59:2001;1-8.
14. Eddy N.B., Leimbach D. Synthetic analgesics: II. Dithienylbutenyl and dithienylbutylamines. J. Pharmacol. Exp. Ther. 107:1953;385-393.
15. Farzin D., Attarzadeh M. Influence of different histamine receptor agonists and antagonists on apomorphine-induced licking behavior in rat. Eur. J. Pharmacol. 404:2000;169-174.
16. Farzin D., Asghari L., Nowrouzi M. Rodent antinociception following acute treatment with different histamine receptor agonists and antagonists. Pharmacol. Biochem. Behav. 72:2002;751-760.
17. 3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia. Behav. Brain Res. 104:1999;147-155.
18. Gouarderes C., Sutak M., Zajac J.M., Jhamandas K. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur. J. Pharmacol. 237:1993;73-81.
19. Gouarderes C., Sutak M., Zajac J.M., Jhamandas K. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs. Eur. J. Pharmacol. 406:2000;391-401.
20. Hammond D.L. Intrathecal administration: methodological considerations. Besson J.M. Progress in Brain Research. 1988;313-320 Elsevier, New York.
21. 3-receptors in guinea-pig cerebral cortex and ileum longitudinal muscle myenteric plexus. Br. J. Pharmacol. 128:1999;751-759.
22. Heron A., Rouleau A., Cochois V., Pillot C., Schwartz J.C., Arrang J.M. Expression analysis of the histamine H(3) receptor in developing rat tissues. Mech. Dev. 105:2001;167-173.
23. 1 receptor activation. Eur. J. Pharmacol. 211:1992;421-426.
24. Hill S.J., Ganellin C.R., Timmerman H., Schwartz J.C., Shankley N.P., Young J.M., Schunack W., Levi R., Haas H.L. International Union of Pharmacology: XIII. Classification of histamine receptors. Pharmacol. Rev. 49:1997;253-278.
25. Hough L. Genomics meets histamine receptors: new subtypes, new receptors. Mol. Pharmacol. 59:2001;415-419.
26. Hough L., Leurs R. Physiology and pharmacology of histamine receptors. Davis C.H., Pangalos M.N. Structure and Function of GPCRs in the Nervous System. 2002;307-348 Oxford Univ. Press, Oxford.
27. Hylden J.L., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:1980;313-316.
28. 3-receptor-mediated inhibition of calcitonin gene-related peptide release from cardiac C fibers. A regulatory negative-feedback loop. Circ. Res. 78:1996;863-869.
29. 3 receptor ligands, immepip and clobenpropit. Effects of intrahypothalamic and peripheral application. Eur. J. Pharmacol. 362:1998;149-155.
30. 3 receptor agonists. J. Med. Chem. 38:1995;4070-4079.
31. Kuraishi Y., Hirota N., Sato Y., Hino Y., Satoh M., Takagi H. Evidence that substance P and somatostatin transmit separate information related to pain in the spinal dorsal horn. Brain Res. 325:1985;294-298.
32. Kuraishi Y., Kawamura M., Yamaguchi T., Houtani T., Kawabata S., Futaki S., Fujii N., Satoh M. Intrathecal injections of galanin and its antiserum affect nociceptive response of rat to mechanical, but not thermal, stimuli. Pain. 44:1991;321-324.
33. 3 receptor. Mol. Pharmacol. 55:1999;1101-1107.
34. Lovenberg T.W., Pyati J., Chang H., Wilson S.J., Erlander M.G. Cloning of rat histamine H(3) receptor reveals distinct species pharmacological profiles. J. Pharmacol. Exp. Ther. 293:2000;771-778.
35. Machelska H., Pavone F., Capone F., Przewlocka B. Antinociception after both peripheral and intrathecal injection of oxotremorine is modulated by spinal nitric oxide. Eur. Neuropsychopharmacol. 9:1999;213-217.
36. Magerl W., Fuchs P.N., Meyer R.A., Treede R.D. Roles of capsaicin-insensitive nociceptors in cutaneous pain and secondary hyperalgesia. Brain. 124:2001;1754-1764.
37. Malmberg-Aiello P., Lamberti C., Ghelardini C., Giotti A., Bartolini A. Role of histamine in rodent antinociception. Br. J. Pharmacol. 111:1994;1269-1279.
38. 3 receptors regulates histamine neurons in brain. Nature. 408:2000;860-864.
39. 3 receptor agonist, on C-fibers, cholinergic fibers and mast cells in rabbit lungs in vitro. Eur. J. Pharmacol. 371:1999;23-30.
40. 3 receptors. Eur. J. Pharmacol. 273:1995;83-88.
41. Okada M., Nakagawa T., Minami M., Satoh M. Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats. J. Pharmacol. Exp. Ther. 303:2002;66-73.
42. Parsons C.G., Headley P.M. Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus. Br. J. Pharmacol. 98:1989;523-532.
43. 3 receptors in rat brain areas. Neuroscience. 52:1993;169-189.
44. Przewlocki R., Labuz D., Mika J., Przewlocka B., Tomboly C., Toth G. Pain inhibition by endomorphins. Ann. N.Y. Acad. Sci. 897:1999;154-164.
45. Ringkamp M., Peng Y.B., Wu G., Hartke T.V., Campbell J.N., Meyer R.A. Capsaicin responses in heat-sensitive and heat-insensitive A-fiber nociceptors. J. Neurosci. 21:2001;4460-4468.
46. 3 receptor agonist prodrug. J. Pharmacol. Exp. Ther. 281:1997;1085-1094.
47. Rouleau A., Stark H., Schunack W., Schwartz J.C. Anti-inflammatory and antinociceptive properties of BP 2-94, a histamine H(3)-receptor agonist prodrug. J. Pharmacol. Exp. Ther. 295:2000;219-225.
48. Sewell R.D., Spencer P.S. Antinociceptive activity of narcotic agonist and partial agonist analgesics and other agents in the tail-immersion test in mice and rats. Neuropharmacology. 15:1976;683-688.
49. Sherman S., Loomis C., Milne B., Cervenko F. Prolonged spinal analgesia in the rat with the alpha-adrenoceptor agonist oxymetazoline. Eur. J. Pharmacol. 140:1987;25-32.
50. Storck T., Kruth U., Kolhekar R., Sprengel R., Seeburg P.H. Rapid construction in yeast of complex targeting vectors for gene manipulation in the mouse. Nucleic Acids Res. 24:1996;4594-4596.
51. Szolcsanyi J., Anton F., Reeh P.W., Handwerker H.O. Selective excitation by capsaicin of mechano-heat sensitive nociceptors in rat skin. Brain Res. 446:1988;262-268.
52. 3 receptors results in changes in brain histamine tone leading to an obese phenotype. J. Clin. Invest. 110:2002;1791-1799.
53. 3 receptor: evidence for two isoforms. Neuroreport. 11:2000;755-759.
54. 3 receptors by thioperamide and (R)-alpha-methylhistamine measured using histamine turnover and an ex vivo labeling technique. Biochem. Pharmacol. 44:1992;1261-1267.
55. Toyota H., Dugovic C., Koehl M., Laposky A.D., Weber C., Ngo K., Wu Y., Lee D.H., Yanai K., Sakurai E., Watanabe T., Liu C., Chen J., Barbier A.J., Turek F.W., Fung-Leung W.P., Lovenberg T.W. Behavioral characterization of mice lacking histamine H(3) receptors. Mol. Pharmacol. 62:2002;389-397.
56. 3 receptor agonist, 4-(1 H-imidazol-4-ylmethyl)piperidine. J. Med. Chem. 37:1994;332-333.
57. Von Bergen N.H., Subieta A., Brennan T.J. Effect of intrathecal non-NMDA EAA receptor antagonist LY293558 in rats: a new class of drugs for spinal anesthesia. Anesthesiology. 97:2002;177-182.
58. Wellendorph P., Goodman M.W., Burstein E.S., Nash N.R., Brann M.R., Weiner D.M. Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H(3) receptor. Neuropharmacology. 42:2002;929-940.
59. Yaksh T., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17:1976;1031-1036.
60. 3-receptor agonist, in rats. J. Pharm. Pharmacol. 46:1994;371-374.
61. Yeomans D.C., Proudfit H.K. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: electrophysiological evidence. Pain. 68:1996;141-150.